Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
90.29
-0.52 (-0.57%)
Aug 17, 2026, 9:31 AM EDT - Market open
Haemonetics Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 27, 2026 | Mar '26 Mar 28, 2026 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 |
Net Income | 96.29 | 97.31 | 167.68 | 117.56 | 115.4 | 43.38 |
Depreciation & Amortization | 103.97 | 105.62 | 108.89 | 88.62 | 84.81 | 86.55 |
Other Amortization | 6.1 | 6.1 | 6.7 | 8.6 | 8.5 | 11.8 |
Loss (Gain) From Sale of Assets | -0.71 | -0.71 | -15.7 | -1.01 | -0.94 | -9.6 |
Asset Writedown & Restructuring Costs | 86.55 | 86.55 | 2.39 | 10.42 | 0.61 | 10.75 |
Stock-Based Compensation | 33.83 | 33.83 | 29.64 | 28.33 | 25.58 | 24.36 |
Other Operating Activities | -9.69 | -11.81 | -15.91 | 3.94 | 13.6 | 20.21 |
Change in Accounts Receivable | -18.14 | -14.88 | 6.96 | -24.19 | -24.42 | -34.97 |
Change in Inventory | 43.06 | 47.36 | -64.7 | -60.06 | 30.75 | 24.31 |
Change in Accounts Payable | 18.71 | -16.57 | -19.21 | 44.58 | 39.82 | 7.64 |
Change in Income Taxes | -1.78 | -4.53 | 0.23 | -0.98 | 1.69 | 2.87 |
Change in Other Net Operating Assets | -30.03 | -35.03 | -25.23 | -34.05 | -22.33 | -15.02 |
Operating Cash Flow | 328.15 | 293.22 | 181.73 | 181.75 | 273.06 | 172.26 |
Operating Cash Flow Growth | 44.85% | 61.35% | -0.01% | -33.44% | 58.51% | 58.32% |
Capital Expenditures | -36.93 | -32.78 | -39.28 | -38.13 | -191.33 | -96.51 |
Sale of Property, Plant & Equipment | 1.32 | 1.38 | 23.25 | 1.81 | 1.61 | 2.02 |
Cash Acquisitions | -60.18 | -60.18 | -150.91 | -243.85 | -2.85 | -2.5 |
Divestitures | - | - | 43.29 | 1.5 | 0.85 | 10.64 |
Investment in Securities | -26.99 | -36.07 | -17.14 | -15.55 | -33.21 | - |
Other Investing Activities | -46 | -51.89 | -21.11 | -28.17 | 81.14 | - |
Investing Cash Flow | -168.78 | -179.55 | -161.9 | -322.39 | -143.79 | -86.35 |
Long-Term Debt Issued | - | 300 | 950 | 110 | 330 | - |
Total Debt Issued | 300 | 300 | 950 | 110 | 330 | - |
Long-Term Debt Repaid | - | -306.25 | -502.69 | -72.25 | -339.63 | -17.5 |
Total Debt Repaid | -356.25 | -306.25 | -502.69 | -72.25 | -339.63 | -17.5 |
Net Debt Issued (Repaid) | -56.25 | -6.25 | 447.31 | 37.75 | -9.63 | -17.5 |
Issuance of Common Stock | 7.5 | 7.89 | 8.33 | 7.21 | 7.02 | 6.55 |
Repurchase of Common Stock | -178.72 | -180 | -235.24 | -5.89 | -75 | - |
Other Financing Activities | -0.08 | -0.1 | -111.58 | -0.92 | -22.76 | -4.8 |
Financing Cash Flow | -227.55 | -178.46 | 108.82 | 38.16 | -100.36 | -15.75 |
Foreign Exchange Rate Adjustments | -1.34 | 3.46 | -0.69 | -3.19 | -3.94 | -2.98 |
Net Cash Flow | -69.51 | -61.32 | 127.96 | -105.67 | 24.97 | 67.19 |
Free Cash Flow | 291.22 | 260.44 | 142.45 | 143.63 | 81.73 | 75.75 |
Free Cash Flow Growth | 53.95% | 82.83% | -0.82% | 75.73% | 7.89% | 5.56% |
Free Cash Flow Margin | 21.54% | 19.52% | 10.47% | 10.97% | 6.99% | 7.63% |
Free Cash Flow Per Share | 6.24 | 5.50 | 2.81 | 2.79 | 1.59 | 1.48 |
Levered Free Cash Flow | 312.84 | 298.09 | 183.89 | 148.53 | 50.09 | 88.9 |
Unlevered Free Cash Flow | 329.97 | 310.16 | 206.33 | 160.72 | 58.21 | 89.12 |
Cash Interest Paid | 17.47 | 17.47 | 16.53 | 20.9 | 13.59 | 6.19 |
Cash Income Tax Paid | 60.67 | 60.67 | 49.29 | 52.71 | 17.97 | 24.3 |
Change in Working Capital | 11.83 | -23.65 | -101.96 | -74.7 | 25.5 | -15.18 |